Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60407852 |
2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.54694694 |
3 | neutrophil activation involved in immune response (GO:0002283) | 5.17086006 |
4 | regulation of activation of Janus kinase activity (GO:0010533) | 4.97554038 |
5 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.88811869 |
6 | response to peptidoglycan (GO:0032494) | 4.77984245 |
7 | type I interferon signaling pathway (GO:0060337) | 4.50555684 |
8 | cellular response to type I interferon (GO:0071357) | 4.50555684 |
9 | response to type I interferon (GO:0034340) | 4.44068705 |
10 | defense response to protozoan (GO:0042832) | 4.43610484 |
11 | immunoglobulin mediated immune response (GO:0016064) | 4.42036518 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.41601080 |
13 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.35446133 |
14 | T cell migration (GO:0072678) | 4.31074764 |
15 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.28114483 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.21500212 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21500212 |
18 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.18652210 |
19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17682915 |
20 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.15808291 |
21 | myeloid dendritic cell differentiation (GO:0043011) | 4.14983670 |
22 | neutrophil activation (GO:0042119) | 4.12020609 |
23 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.11884792 |
24 | positive regulation of interferon-alpha production (GO:0032727) | 4.11548311 |
25 | response to interferon-alpha (GO:0035455) | 4.05461609 |
26 | response to interferon-beta (GO:0035456) | 4.05283664 |
27 | negative regulation of interleukin-17 production (GO:0032700) | 4.03113408 |
28 | myeloid dendritic cell activation (GO:0001773) | 3.99154078 |
29 | granulocyte activation (GO:0036230) | 3.97973333 |
30 | B cell proliferation (GO:0042100) | 3.92415358 |
31 | negative regulation of viral genome replication (GO:0045071) | 3.92404088 |
32 | regulation of interferon-alpha production (GO:0032647) | 3.91612674 |
33 | NIK/NF-kappaB signaling (GO:0038061) | 3.90820572 |
34 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.89795170 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.88144931 |
36 | positive regulation of interleukin-12 production (GO:0032735) | 3.87686361 |
37 | B cell receptor signaling pathway (GO:0050853) | 3.87428291 |
38 | response to protozoan (GO:0001562) | 3.83426794 |
39 | B cell mediated immunity (GO:0019724) | 3.81298420 |
40 | * T-helper 1 type immune response (GO:0042088) | 3.78047338 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77383275 |
42 | positive regulation of interleukin-17 production (GO:0032740) | 3.76860554 |
43 | regulation of T-helper cell differentiation (GO:0045622) | 3.76441591 |
44 | negative regulation of interleukin-12 production (GO:0032695) | 3.73596562 |
45 | regulation of RIG-I signaling pathway (GO:0039535) | 3.71474342 |
46 | B cell homeostasis (GO:0001782) | 3.71331163 |
47 | positive regulation of type 2 immune response (GO:0002830) | 3.70401719 |
48 | cellular response to zinc ion (GO:0071294) | 3.68496697 |
49 | T cell lineage commitment (GO:0002360) | 3.67750845 |
50 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.64831124 |
51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.63839808 |
52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.63839219 |
53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63404117 |
54 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.63130798 |
55 | cellular response to interferon-beta (GO:0035458) | 3.61263686 |
56 | regulation of interleukin-17 production (GO:0032660) | 3.59162690 |
57 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.58714235 |
58 | regulation of memory T cell differentiation (GO:0043380) | 3.55823312 |
59 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.53476336 |
60 | positive regulation of B cell mediated immunity (GO:0002714) | 3.53476336 |
61 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52632999 |
62 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.52500881 |
63 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.51441936 |
64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.49884616 |
65 | response to muramyl dipeptide (GO:0032495) | 3.48892435 |
66 | regulation of T-helper 1 type immune response (GO:0002825) | 3.48450895 |
67 | activation of MAPKKK activity (GO:0000185) | 3.48109909 |
68 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.47195469 |
69 | positive regulation of macrophage cytokine production (GO:0060907) | 3.44922294 |
70 | respiratory burst (GO:0045730) | 3.44350199 |
71 | negative regulation of cell killing (GO:0031342) | 3.42425767 |
72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.42425767 |
73 | germinal center formation (GO:0002467) | 3.42394502 |
74 | regulation of natural killer cell differentiation (GO:0032823) | 3.41924196 |
75 | detection of bacterium (GO:0016045) | 3.41603711 |
76 | regulation of hypersensitivity (GO:0002883) | 3.40611579 |
77 | dendritic cell differentiation (GO:0097028) | 3.40134252 |
78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.36788614 |
79 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35407228 |
80 | modulation by symbiont of host defense response (GO:0052031) | 3.35407228 |
81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35407228 |
82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35407228 |
83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35407228 |
84 | modulation by symbiont of host immune response (GO:0052553) | 3.35407228 |
85 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.35176364 |
86 | natural killer cell mediated immunity (GO:0002228) | 3.35176364 |
87 | * regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.34961329 |
88 | macrophage activation involved in immune response (GO:0002281) | 3.33356184 |
89 | * positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.30936648 |
90 | positive regulation of humoral immune response (GO:0002922) | 3.30088254 |
91 | T cell costimulation (GO:0031295) | 3.28172901 |
92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25581922 |
93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24880391 |
94 | regulation of antigen processing and presentation (GO:0002577) | 3.23797717 |
95 | lymphocyte costimulation (GO:0031294) | 3.23152813 |
96 | detection of other organism (GO:0098543) | 3.22558206 |
97 | leukocyte aggregation (GO:0070486) | 3.20177179 |
98 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.20088389 |
99 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.19476558 |
100 | regulation of B cell proliferation (GO:0030888) | 3.19063911 |
101 | positive regulation of B cell differentiation (GO:0045579) | 3.18920640 |
102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18842712 |
103 | regulation of interleukin-12 production (GO:0032655) | 3.18592779 |
104 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.18011721 |
105 | positive regulation of B cell proliferation (GO:0030890) | 3.16823668 |
106 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.13540470 |
107 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.13180155 |
108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.13100716 |
109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.12461015 |
110 | cellular response to exogenous dsRNA (GO:0071360) | 3.11058196 |
111 | leukocyte mediated cytotoxicity (GO:0001909) | 3.10910372 |
112 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.10072851 |
113 | positive regulation of activated T cell proliferation (GO:0042104) | 3.08902091 |
114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.08835641 |
115 | positive regulation of natural killer cell activation (GO:0032816) | 3.07868069 |
116 | negative thymic T cell selection (GO:0045060) | 3.06824501 |
117 | positive regulation of interleukin-2 production (GO:0032743) | 3.06348546 |
118 | regulation of natural killer cell activation (GO:0032814) | 3.05159887 |
119 | positive regulation of interleukin-10 production (GO:0032733) | 3.03363094 |
120 | natural killer cell differentiation (GO:0001779) | 3.02544950 |
121 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02324218 |
122 | negative regulation of B cell proliferation (GO:0030889) | 3.01431948 |
123 | natural killer cell activation (GO:0030101) | 3.01321355 |
124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98446296 |
125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97513023 |
126 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97371676 |
127 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97142823 |
128 | positive regulation of defense response to virus by host (GO:0002230) | 2.95902665 |
129 | positive regulation of interferon-beta production (GO:0032728) | 2.95727008 |
130 | regulation of immunoglobulin secretion (GO:0051023) | 2.95615105 |
131 | regulation of interleukin-10 production (GO:0032653) | 2.95413590 |
132 | regulation of B cell apoptotic process (GO:0002902) | 2.95268552 |
133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93362890 |
134 | regulation of B cell differentiation (GO:0045577) | 2.92664798 |
135 | regulation of chronic inflammatory response (GO:0002676) | 2.92467236 |
136 | myeloid cell activation involved in immune response (GO:0002275) | 2.92418176 |
137 | cellular response to interferon-gamma (GO:0071346) | 2.88988314 |
138 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88830437 |
139 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87457445 |
140 | response to interferon-gamma (GO:0034341) | 2.87434321 |
141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87010220 |
142 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.86684995 |
143 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86596092 |
144 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.86441860 |
145 | regulation of growth of symbiont in host (GO:0044126) | 2.86441860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.46969671 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.38233280 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.28975280 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.99155602 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.40809459 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.78311867 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70886378 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68947747 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.59964581 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34950708 |
11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.32840318 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22826559 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21696007 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.07377572 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.03355021 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76708326 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.73195753 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65577107 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62485192 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.61567925 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52721871 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33881488 |
23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27623176 |
24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16337745 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16080102 |
26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05610853 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 2.04928912 |
28 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02284769 |
29 | MAF_26560356_Chip-Seq_TH1_Human | 1.91091433 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86751129 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85081760 |
32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83909325 |
33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83389711 |
34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81570700 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81004205 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79862355 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.77692731 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76741075 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71590329 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66787694 |
41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63784020 |
42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61934780 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56079132 |
44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53070228 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51466460 |
46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50944577 |
47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50617593 |
48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49889046 |
49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49888427 |
50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47219115 |
51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44711426 |
52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43045544 |
53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38845757 |
54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37759973 |
55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36371087 |
56 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34649410 |
57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34231028 |
58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33796874 |
59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32315577 |
60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29812643 |
61 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27631224 |
62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27135527 |
63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26702509 |
64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26465189 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25160785 |
66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25122332 |
67 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.23339064 |
68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22235063 |
69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21597956 |
70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19445894 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19103607 |
72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18802970 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16609425 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16250234 |
75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15434882 |
76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13516698 |
77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13262049 |
78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13019242 |
79 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11906681 |
80 | MAF_26560356_Chip-Seq_TH2_Human | 1.10364499 |
81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08302331 |
82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07626490 |
83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05671823 |
84 | MYC_22102868_ChIP-Seq_BL_Human | 1.04330353 |
85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02243640 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01306463 |
87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99996927 |
88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98805445 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98388288 |
90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96762659 |
91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94021177 |
92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93642925 |
93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90469338 |
94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90176235 |
95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89357243 |
96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88130546 |
97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.86103704 |
98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85705390 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83036115 |
100 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82033059 |
101 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81353460 |
102 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.81224641 |
103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79345835 |
104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79074453 |
105 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.77503595 |
106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77385995 |
107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.75217585 |
108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74521509 |
109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74144060 |
110 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.74052184 |
111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.73950894 |
112 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.73257913 |
113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72514558 |
114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.71833940 |
115 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.71234464 |
116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.69872300 |
117 | P300_27268052_Chip-Seq_Bcells_Human | 0.68473282 |
118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.67430896 |
119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67211964 |
120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.66265058 |
121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.65948964 |
122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.63504234 |
123 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63173479 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.47328400 |
2 | MP0009785_altered_susceptibility_to | 4.64755157 |
3 | MP0002148_abnormal_hypersensitivity_rea | 4.01756075 |
4 | * MP0000685_abnormal_immune_system | 3.83979337 |
5 | MP0005671_abnormal_response_to | 3.71077537 |
6 | MP0003436_decreased_susceptibility_to | 3.68943022 |
7 | MP0005000_abnormal_immune_tolerance | 3.25097499 |
8 | * MP0005025_abnormal_response_to | 3.21545539 |
9 | * MP0005387_immune_system_phenotype | 3.07121223 |
10 | * MP0001790_abnormal_immune_system | 3.07121223 |
11 | MP0002419_abnormal_innate_immunity | 2.94678268 |
12 | MP0001800_abnormal_humoral_immune | 2.83812948 |
13 | MP0002452_abnormal_antigen_presenting | 2.78950777 |
14 | * MP0002723_abnormal_immune_serum | 2.72462940 |
15 | MP0003724_increased_susceptibility_to | 2.60716110 |
16 | MP0006082_CNS_inflammation | 2.57858726 |
17 | MP0001819_abnormal_immune_cell | 2.52370374 |
18 | MP0002420_abnormal_adaptive_immunity | 2.48400371 |
19 | MP0003303_peritoneal_inflammation | 2.22191729 |
20 | MP0005645_abnormal_hypothalamus_physiol | 2.21815161 |
21 | MP0001853_heart_inflammation | 2.19883175 |
22 | MP0002166_altered_tumor_susceptibility | 2.17235901 |
23 | MP0005464_abnormal_platelet_physiology | 2.15837999 |
24 | MP0002006_tumorigenesis | 2.13092819 |
25 | MP0004510_myositis | 2.12888614 |
26 | MP0001348_abnormal_lacrimal_gland | 2.07698431 |
27 | * MP0002398_abnormal_bone_marrow | 2.02451041 |
28 | * MP0000716_abnormal_immune_system | 1.97524480 |
29 | MP0002405_respiratory_system_inflammati | 1.95129809 |
30 | MP0001545_abnormal_hematopoietic_system | 1.89233176 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.89233176 |
32 | * MP0001845_abnormal_inflammatory_respons | 1.87558787 |
33 | MP0009764_decreased_sensitivity_to | 1.85233066 |
34 | MP0002139_abnormal_hepatobiliary_system | 1.84535574 |
35 | MP0002163_abnormal_gland_morphology | 1.80780811 |
36 | MP0005310_abnormal_salivary_gland | 1.79412949 |
37 | MP0005451_abnormal_body_composition | 1.77991093 |
38 | * MP0010155_abnormal_intestine_physiology | 1.75088429 |
39 | MP0001533_abnormal_skeleton_physiology | 1.73402828 |
40 | MP0002396_abnormal_hematopoietic_system | 1.65393847 |
41 | * MP0008469_abnormal_protein_level | 1.62736604 |
42 | * MP0002429_abnormal_blood_cell | 1.61638793 |
43 | MP0003763_abnormal_thymus_physiology | 1.60392354 |
44 | MP0000689_abnormal_spleen_morphology | 1.59989024 |
45 | MP0004947_skin_inflammation | 1.53637081 |
46 | MP0002722_abnormal_immune_system | 1.52923090 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.52554860 |
48 | MP0004808_abnormal_hematopoietic_stem | 1.43884884 |
49 | MP0005174_abnormal_tail_pigmentation | 1.43201480 |
50 | MP0005058_abnormal_lysosome_morphology | 1.40275420 |
51 | MP0002254_reproductive_system_inflammat | 1.35266615 |
52 | MP0000343_altered_response_to | 1.28203766 |
53 | MP0009278_abnormal_bone_marrow | 1.27189571 |
54 | MP0003172_abnormal_lysosome_physiology | 1.25361397 |
55 | MP0005623_abnormal_meninges_morphology | 1.17563233 |
56 | MP0003075_altered_response_to | 1.16639086 |
57 | MP0003191_abnormal_cellular_cholesterol | 1.13966530 |
58 | MP0003866_abnormal_defecation | 1.13058301 |
59 | MP0003453_abnormal_keratinocyte_physiol | 1.12519026 |
60 | MP0003448_altered_tumor_morphology | 1.12439863 |
61 | MP0001346_abnormal_lacrimal_gland | 1.11441574 |
62 | MP0000490_abnormal_crypts_of | 1.08414894 |
63 | MP0003186_abnormal_redox_activity | 1.07032012 |
64 | MP0003183_abnormal_peptide_metabolism | 1.06287086 |
65 | MP0000858_altered_metastatic_potential | 1.05031801 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.04341169 |
67 | MP0001873_stomach_inflammation | 1.04305801 |
68 | MP0002138_abnormal_hepatobiliary_system | 1.03582627 |
69 | MP0005647_abnormal_sex_gland | 1.00418313 |
70 | MP0005379_endocrine/exocrine_gland_phen | 0.97663352 |
71 | MP0000015_abnormal_ear_pigmentation | 0.97498168 |
72 | MP0009763_increased_sensitivity_to | 0.96383705 |
73 | MP0000703_abnormal_thymus_morphology | 0.94890584 |
74 | MP0009697_abnormal_copulation | 0.94023298 |
75 | MP0003045_fibrosis | 0.93575145 |
76 | MP0009840_abnormal_foam_cell | 0.89828841 |
77 | MP0002933_joint_inflammation | 0.89543535 |
78 | MP0008057_abnormal_DNA_replication | 0.88851179 |
79 | MP0001727_abnormal_embryo_implantation | 0.88398079 |
80 | MP0003806_abnormal_nucleotide_metabolis | 0.85587387 |
81 | MP0005075_abnormal_melanosome_morpholog | 0.82544079 |
82 | MP0000465_gastrointestinal_hemorrhage | 0.82360064 |
83 | MP0004782_abnormal_surfactant_physiolog | 0.82234441 |
84 | MP0002998_abnormal_bone_remodeling | 0.81472915 |
85 | MP0000604_amyloidosis | 0.75794465 |
86 | MP0005390_skeleton_phenotype | 0.73320619 |
87 | MP0002095_abnormal_skin_pigmentation | 0.73070146 |
88 | MP0003300_gastrointestinal_ulcer | 0.71394174 |
89 | MP0002877_abnormal_melanocyte_morpholog | 0.70346572 |
90 | MP0002019_abnormal_tumor_incidence | 0.70266720 |
91 | MP0000249_abnormal_blood_vessel | 0.69252272 |
92 | MP0008874_decreased_physiological_sensi | 0.67956635 |
93 | MP0005166_decreased_susceptibility_to | 0.67929556 |
94 | MP0002332_abnormal_exercise_endurance | 0.67013819 |
95 | MP0003943_abnormal_hepatobiliary_system | 0.65930204 |
96 | MP0005165_increased_susceptibility_to | 0.64964403 |
97 | MP0010307_abnormal_tumor_latency | 0.64892127 |
98 | MP0000609_abnormal_liver_physiology | 0.63336885 |
99 | MP0003828_pulmonary_edema | 0.62078118 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.61076303 |
101 | MP0002136_abnormal_kidney_physiology | 0.60348422 |
102 | MP0001919_abnormal_reproductive_system | 0.59231837 |
103 | MP0000371_diluted_coat_color | 0.58796781 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.58734437 |
105 | MP0000681_abnormal_thyroid_gland | 0.57762805 |
106 | MP0002009_preneoplasia | 0.56709888 |
107 | MP0002693_abnormal_pancreas_physiology | 0.56363181 |
108 | MP0001986_abnormal_taste_sensitivity | 0.55753640 |
109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55384777 |
110 | MP0008007_abnormal_cellular_replicative | 0.54899772 |
111 | MP0009046_muscle_twitch | 0.53969011 |
112 | MP0005164_abnormal_response_to | 0.53356907 |
113 | MP0010094_abnormal_chromosome_stability | 0.52669971 |
114 | MP0000569_abnormal_digit_pigmentation | 0.52256566 |
115 | MP0000313_abnormal_cell_death | 0.49887039 |
116 | MP0003656_abnormal_erythrocyte_physiolo | 0.49411160 |
117 | MP0001663_abnormal_digestive_system | 0.48814489 |
118 | MP0001851_eye_inflammation | 0.48583960 |
119 | MP0003091_abnormal_cell_migration | 0.47918198 |
120 | MP0008260_abnormal_autophagy | 0.47506924 |
121 | MP0009115_abnormal_fat_cell | 0.47398097 |
122 | MP0002876_abnormal_thyroid_physiology | 0.45369978 |
123 | MP0002132_abnormal_respiratory_system | 0.44095478 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.41865712 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.07346997 |
3 | Eczematoid dermatitis (HP:0000976) | 5.80363993 |
4 | Recurrent sinusitis (HP:0011108) | 5.65992174 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.60852386 |
6 | Myositis (HP:0100614) | 5.60295198 |
7 | Increased IgM level (HP:0003496) | 4.95960088 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 4.85473095 |
9 | Abnormality of macrophages (HP:0004311) | 4.73537670 |
10 | Orchitis (HP:0100796) | 4.70922123 |
11 | Optic neuritis (HP:0100653) | 4.65698301 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.65698301 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.55094126 |
14 | Emphysema (HP:0002097) | 4.48991676 |
15 | Mediastinal lymphadenopathy (HP:0100721) | 4.30624177 |
16 | Vasculitis (HP:0002633) | 4.22630583 |
17 | Chronic otitis media (HP:0000389) | 4.10893126 |
18 | Recurrent skin infections (HP:0001581) | 3.94779441 |
19 | Recurrent fungal infections (HP:0002841) | 3.91970946 |
20 | Thrombocytosis (HP:0001894) | 3.79345549 |
21 | Restrictive lung disease (HP:0002091) | 3.66071335 |
22 | Recurrent viral infections (HP:0004429) | 3.63034414 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61114387 |
24 | Hypergammaglobulinemia (HP:0010702) | 3.54165560 |
25 | Stomatitis (HP:0010280) | 3.49695250 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43478734 |
27 | Obstructive lung disease (HP:0006536) | 3.43478734 |
28 | Meningitis (HP:0001287) | 3.28535274 |
29 | Cellulitis (HP:0100658) | 3.22122253 |
30 | Gastrointestinal infarctions (HP:0005244) | 3.20469870 |
31 | Abnormality of T cell physiology (HP:0011840) | 3.17454017 |
32 | Basal ganglia calcification (HP:0002135) | 3.09196453 |
33 | Interstitial pulmonary disease (HP:0006530) | 3.07914780 |
34 | Arterial thrombosis (HP:0004420) | 3.03242911 |
35 | Hypertensive crisis (HP:0100735) | 3.01125492 |
36 | Gingivitis (HP:0000230) | 2.99975081 |
37 | Petechiae (HP:0000967) | 2.99611445 |
38 | B lymphocytopenia (HP:0010976) | 2.99286316 |
39 | Periodontitis (HP:0000704) | 2.98476244 |
40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97136599 |
41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97136599 |
42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97136599 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96551220 |
44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96551220 |
45 | Autoimmune hemolytic anemia (HP:0001890) | 2.93461834 |
46 | Urticaria (HP:0001025) | 2.87457044 |
47 | Keratoconjunctivitis sicca (HP:0001097) | 2.86270918 |
48 | Amaurosis fugax (HP:0100576) | 2.86164516 |
49 | Vacuolated lymphocytes (HP:0001922) | 2.83622555 |
50 | Hemoptysis (HP:0002105) | 2.80986484 |
51 | Pulmonary infiltrates (HP:0002113) | 2.80770774 |
52 | Leukopenia (HP:0001882) | 2.72021046 |
53 | Recurrent bronchitis (HP:0002837) | 2.70837161 |
54 | Gingival bleeding (HP:0000225) | 2.70791670 |
55 | Leukocytosis (HP:0001974) | 2.69970744 |
56 | Agammaglobulinemia (HP:0004432) | 2.69278740 |
57 | Tetraparesis (HP:0002273) | 2.68329039 |
58 | Abnormality of B cell number (HP:0010975) | 2.67331586 |
59 | Lymphoma (HP:0002665) | 2.66290278 |
60 | IgM deficiency (HP:0002850) | 2.66133173 |
61 | IgG deficiency (HP:0004315) | 2.63545152 |
62 | Systemic lupus erythematosus (HP:0002725) | 2.63399461 |
63 | Abnormality of T cells (HP:0002843) | 2.62259222 |
64 | Keratoconjunctivitis (HP:0001096) | 2.61937164 |
65 | Recurrent pneumonia (HP:0006532) | 2.61353625 |
66 | Bronchitis (HP:0012387) | 2.58923797 |
67 | Chest pain (HP:0100749) | 2.58220392 |
68 | Premature loss of primary teeth (HP:0006323) | 2.57390487 |
69 | Encephalitis (HP:0002383) | 2.55351780 |
70 | Spontaneous hematomas (HP:0007420) | 2.52685182 |
71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50404117 |
72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.49390437 |
73 | Basal cell carcinoma (HP:0002671) | 2.47676574 |
74 | Eosinophilia (HP:0001880) | 2.46082141 |
75 | Panhypogammaglobulinemia (HP:0003139) | 2.45528684 |
76 | Epistaxis (HP:0000421) | 2.45362099 |
77 | Skin rash (HP:0000988) | 2.39824967 |
78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39345016 |
79 | Xerostomia (HP:0000217) | 2.38829117 |
80 | Granulocytopenia (HP:0001913) | 2.37900015 |
81 | Dry hair (HP:0011359) | 2.37265218 |
82 | Abnormality of the nasal mucosa (HP:0000433) | 2.35740890 |
83 | Pustule (HP:0200039) | 2.34862534 |
84 | Verrucae (HP:0200043) | 2.34592000 |
85 | Papilloma (HP:0012740) | 2.34592000 |
86 | Nasal polyposis (HP:0100582) | 2.31997259 |
87 | Lymphopenia (HP:0001888) | 2.31136983 |
88 | Inflammation of the large intestine (HP:0002037) | 2.31026478 |
89 | Osteomyelitis (HP:0002754) | 2.28687852 |
90 | Abnormality of T cell number (HP:0011839) | 2.28276767 |
91 | Joint swelling (HP:0001386) | 2.28068416 |
92 | IgA deficiency (HP:0002720) | 2.27657602 |
93 | Neutropenia (HP:0001875) | 2.25862169 |
94 | Increased IgE level (HP:0003212) | 2.24777120 |
95 | Squamous cell carcinoma (HP:0002860) | 2.23823509 |
96 | Abnormality of eosinophils (HP:0001879) | 2.23293435 |
97 | Vertebral compression fractures (HP:0002953) | 2.23163202 |
98 | Gastrointestinal stroma tumor (HP:0100723) | 2.22533227 |
99 | Increased cerebral lipofuscin (HP:0011813) | 2.21406804 |
100 | Gastrointestinal inflammation (HP:0004386) | 2.21061152 |
101 | Poor head control (HP:0002421) | 2.16975450 |
102 | Purpura (HP:0000979) | 2.16851421 |
103 | Gangrene (HP:0100758) | 2.16746448 |
104 | Chronic diarrhea (HP:0002028) | 2.16280789 |
105 | Anorexia (HP:0002039) | 2.16218894 |
106 | Colitis (HP:0002583) | 2.12848988 |
107 | Arthralgia (HP:0002829) | 2.11829989 |
108 | Prolonged bleeding time (HP:0003010) | 2.09120622 |
109 | Recurrent otitis media (HP:0000403) | 2.08327042 |
110 | Abnormal gallbladder physiology (HP:0012438) | 2.07793680 |
111 | Cholecystitis (HP:0001082) | 2.07793680 |
112 | Acrocyanosis (HP:0001063) | 2.07162933 |
113 | Chronic sinusitis (HP:0011109) | 2.06438493 |
114 | Thyroiditis (HP:0100646) | 2.04465709 |
115 | Albinism (HP:0001022) | 2.04220938 |
116 | Abnormality of the pleura (HP:0002103) | 2.04059193 |
117 | Onycholysis (HP:0001806) | 2.00715604 |
118 | Viral hepatitis (HP:0006562) | 2.00684715 |
119 | Abnormality of the prostate (HP:0008775) | 1.98942668 |
120 | Fatigue (HP:0012378) | 1.98458538 |
121 | Conical tooth (HP:0000698) | 1.98423176 |
122 | Pulmonary fibrosis (HP:0002206) | 1.97223513 |
123 | Reduced antithrombin III activity (HP:0001976) | 1.95138557 |
124 | Hepatitis (HP:0012115) | 1.93704565 |
125 | Hematochezia (HP:0002573) | 1.91709576 |
126 | Skin ulcer (HP:0200042) | 1.91163513 |
127 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89346541 |
128 | Dysostosis multiplex (HP:0000943) | 1.88611801 |
129 | Porencephaly (HP:0002132) | 1.88324716 |
130 | Sepsis (HP:0100806) | 1.88236350 |
131 | Loss of speech (HP:0002371) | 1.84710690 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.79933191 |
2 | IRAK4 | 3.72699420 |
3 | TBK1 | 3.60501879 |
4 | PRPF4B | 3.32374341 |
5 | RIPK4 | 3.11375673 |
6 | JAK3 | 3.08022691 |
7 | TYK2 | 3.05732797 |
8 | IKBKE | 2.97659033 |
9 | IKBKB | 2.76595424 |
10 | KIT | 2.72600093 |
11 | MAP4K1 | 2.69256958 |
12 | BLK | 2.58847398 |
13 | SMG1 | 2.50105309 |
14 | MAP3K13 | 2.37525002 |
15 | PIM2 | 2.21508798 |
16 | FLT3 | 2.19154947 |
17 | IRAK3 | 2.17654735 |
18 | VRK1 | 2.03531659 |
19 | BTK | 2.02632139 |
20 | TXK | 2.01008672 |
21 | DDR2 | 1.92936708 |
22 | SYK | 1.82777706 |
23 | CSF1R | 1.80522964 |
24 | DAPK3 | 1.80044540 |
25 | ZAP70 | 1.74309906 |
26 | CHUK | 1.73040246 |
27 | TLK1 | 1.69808771 |
28 | TAOK2 | 1.68510846 |
29 | JAK1 | 1.63234053 |
30 | NME2 | 1.60680138 |
31 | TEC | 1.56662661 |
32 | EPHB1 | 1.47232931 |
33 | FES | 1.38815628 |
34 | MAP3K12 | 1.37869303 |
35 | ERN1 | 1.37206075 |
36 | TNIK | 1.31593204 |
37 | ARAF | 1.31584601 |
38 | BMPR2 | 1.27902522 |
39 | MATK | 1.26891212 |
40 | LYN | 1.19124983 |
41 | PIM1 | 1.17795844 |
42 | LCK | 1.17572284 |
43 | CSK | 1.15528824 |
44 | HCK | 1.14958191 |
45 | PBK | 1.14848915 |
46 | CDC42BPA | 1.14658293 |
47 | EIF2AK2 | 1.11062602 |
48 | TAF1 | 1.08884161 |
49 | TGFBR2 | 1.07248787 |
50 | TAOK3 | 1.07015205 |
51 | ADRBK2 | 1.05294731 |
52 | RPS6KA5 | 1.02225515 |
53 | ACVR1B | 0.97395811 |
54 | SIK3 | 0.95138791 |
55 | TGFBR1 | 0.94957955 |
56 | BCKDK | 0.93745807 |
57 | NEK9 | 0.90201714 |
58 | MAP2K3 | 0.89185165 |
59 | NLK | 0.88287285 |
60 | ZAK | 0.87492783 |
61 | VRK2 | 0.85942632 |
62 | JAK2 | 0.85628958 |
63 | STK24 | 0.83381629 |
64 | PKN1 | 0.82663417 |
65 | IRAK1 | 0.81794817 |
66 | RPS6KA4 | 0.81140040 |
67 | ERBB3 | 0.79096975 |
68 | MAP3K9 | 0.75677093 |
69 | CCNB1 | 0.74209922 |
70 | MAPK11 | 0.74034059 |
71 | YES1 | 0.72235753 |
72 | PASK | 0.70976621 |
73 | STK4 | 0.70175756 |
74 | EEF2K | 0.68902267 |
75 | TESK2 | 0.68773147 |
76 | MAP2K6 | 0.65265192 |
77 | PRKCD | 0.64735753 |
78 | FGFR4 | 0.64409875 |
79 | STK10 | 0.63686868 |
80 | ABL2 | 0.63652533 |
81 | FGR | 0.61853194 |
82 | CDK12 | 0.61215222 |
83 | PDGFRA | 0.60909977 |
84 | DAPK1 | 0.59704508 |
85 | FGFR3 | 0.58871256 |
86 | MAP3K8 | 0.58117066 |
87 | SIK2 | 0.57310952 |
88 | BRAF | 0.56794451 |
89 | MELK | 0.55031186 |
90 | MAP3K11 | 0.53697317 |
91 | MAPKAPK2 | 0.53404835 |
92 | CLK1 | 0.53273044 |
93 | MOS | 0.52955451 |
94 | AURKA | 0.52783564 |
95 | IRAK2 | 0.52106335 |
96 | TRPM7 | 0.51740977 |
97 | RAF1 | 0.51012255 |
98 | LRRK2 | 0.50912266 |
99 | EPHA3 | 0.50096268 |
100 | PDK1 | 0.48519297 |
101 | ABL1 | 0.48152312 |
102 | MARK3 | 0.46307165 |
103 | TESK1 | 0.46118864 |
104 | MST4 | 0.44996486 |
105 | PTK6 | 0.44618209 |
106 | NEK1 | 0.44606542 |
107 | MAPKAPK5 | 0.44580657 |
108 | INSR | 0.44363991 |
109 | ALK | 0.42672602 |
110 | MAP3K1 | 0.42287935 |
111 | KDR | 0.41918060 |
112 | MAPK7 | 0.41267953 |
113 | DAPK2 | 0.40206686 |
114 | ICK | 0.39981728 |
115 | SIK1 | 0.38726516 |
116 | TIE1 | 0.38130442 |
117 | BMPR1B | 0.37648024 |
118 | BRSK2 | 0.36596580 |
119 | MAP3K10 | 0.35725378 |
120 | BCR | 0.35560548 |
121 | CDK9 | 0.35542124 |
122 | GRK7 | 0.35485096 |
123 | STK16 | 0.35212578 |
124 | MAP3K5 | 0.33983340 |
125 | RIPK1 | 0.33884353 |
126 | MAPK4 | 0.33617411 |
127 | PRKCQ | 0.33586249 |
128 | MUSK | 0.33265939 |
129 | EGFR | 0.32843761 |
130 | PRKG2 | 0.32295337 |
131 | MAPKAPK3 | 0.31323602 |
132 | GRK6 | 0.31293898 |
133 | WEE1 | 0.31275322 |
134 | RPS6KA6 | 0.30401294 |
135 | CDK4 | 0.30250740 |
136 | CDK6 | 0.29409262 |
137 | HIPK2 | 0.28532196 |
138 | EIF2AK3 | 0.28307559 |
139 | PDPK1 | 0.27507252 |
140 | KSR2 | 0.26783039 |
141 | PIK3CG | 0.25929581 |
142 | PRKCH | 0.24604468 |
143 | CDK19 | 0.24586349 |
144 | TAOK1 | 0.24461050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 4.36648407 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.47920165 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20011245 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.05515815 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.93195983 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.85318471 |
7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.70574676 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68541617 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53584535 |
10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.46406314 |
11 | Measles_Homo sapiens_hsa05162 | 2.35773665 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.30411927 |
13 | Asthma_Homo sapiens_hsa05310 | 2.16442056 |
14 | Legionellosis_Homo sapiens_hsa05134 | 2.13456753 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11830782 |
16 | Pertussis_Homo sapiens_hsa05133 | 2.08451584 |
17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.97904680 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96843992 |
19 | Influenza A_Homo sapiens_hsa05164 | 1.92497316 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88012370 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84054421 |
22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77801972 |
23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.75153561 |
24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68017450 |
25 | Malaria_Homo sapiens_hsa05144 | 1.67768814 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66017074 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63237354 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.61271470 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61205308 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61046281 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.56549119 |
32 | Alcoholism_Homo sapiens_hsa05034 | 1.50618011 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46225214 |
34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43997040 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39483280 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36767115 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36428081 |
38 | Salmonella infection_Homo sapiens_hsa05132 | 1.28369597 |
39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26660640 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.22682422 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.12605657 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03238807 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97594442 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 0.93760183 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93450138 |
46 | Proteasome_Homo sapiens_hsa03050 | 0.92828176 |
47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89820493 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89556487 |
49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88549635 |
50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88255289 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84888367 |
52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84433178 |
53 | Phagosome_Homo sapiens_hsa04145 | 0.78979463 |
54 | Ribosome_Homo sapiens_hsa03010 | 0.76170955 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75974697 |
56 | Lysosome_Homo sapiens_hsa04142 | 0.75757433 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74273751 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73900643 |
59 | DNA replication_Homo sapiens_hsa03030 | 0.71446241 |
60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69482828 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68727718 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.68376186 |
63 | Base excision repair_Homo sapiens_hsa03410 | 0.67015854 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65712212 |
65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56465278 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53935784 |
67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53375283 |
68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52658992 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52555041 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52405148 |
71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47964398 |
72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47929807 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47856319 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.46546511 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46200616 |
76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45257308 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41588092 |
78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41128652 |
79 | Bladder cancer_Homo sapiens_hsa05219 | 0.41099767 |
80 | Prion diseases_Homo sapiens_hsa05020 | 0.34966175 |
81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33660050 |
82 | Mismatch repair_Homo sapiens_hsa03430 | 0.32462487 |
83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29964929 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29709888 |
85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28344625 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26695202 |
87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24589156 |
88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24047103 |
89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23862964 |
90 | Homologous recombination_Homo sapiens_hsa03440 | 0.22112352 |
91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21758210 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21593170 |
93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20250909 |
94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19662874 |
95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16130924 |
96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15608324 |
97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14741215 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14254265 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14150859 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13252045 |
101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12238200 |
102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11319294 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.10798836 |
104 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.09774138 |
105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06139122 |
106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05923999 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05210060 |
108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05197022 |
109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05192528 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05051836 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04324423 |
112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.03917678 |
113 | Prostate cancer_Homo sapiens_hsa05215 | 0.02838189 |
114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.02231961 |
115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01411371 |
116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.01305113 |
117 | Carbon metabolism_Homo sapiens_hsa01200 | -0.0368338 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | -0.0316637 |
119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0133800 |